Kymera Therapeutics, Inc.(KYMR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KYMR Kymera Therapeutics, Inc.

已收盘 05-15 16:00:00 EDT

35.94

+0.85

+2.42%

盘后36.69

+0.75+2.09%

18:29 EDT

最高36.91	最低35.21	成交量66.87万
今开35.67	昨收35.09	日振幅4.86%
总市值22.05亿	流通市值14.51亿	总股本6,136万
成交额2,400万	换手率1.66%	流通股本4,038万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KYMR","market":"US","secType":"STK","nameCN":"Kymera Therapeutics, Inc.","latestPrice":35.94,"timestamp":1715803200000,"preClose":35.09,"halted":0,"volume":668681,"hourTrading":{"tag":"盘后","latestPrice":36.69,"preClose":35.94,"latestTime":"18:29 EDT","volume":211,"amount":7742.67,"timestamp":1715812146656},"delay":0,"floatShares":40381400,"shares":61358262,"eps":-2.513212,"marketStatus":"已收盘","marketStatusCode":5,"change":0.85,"latestTime":"05-15 16:00:00 EDT","open":35.67,"high":36.91,"low":35.205,"amount":23999491.354033,"amplitude":0.048589,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.513212,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715846400000},"adr":0,"listingDate":1597982400000,"adjPreClose":35.09,"postHourTrading":{"tag":"盘后","latestPrice":36.69,"preClose":35.94,"latestTime":"18:29 EDT","volume":211,"amount":7742.67,"timestamp":1715812146656},"volumeRatio":1.235125},"requestUrl":"/m/hq/s/KYMR/","defaultTab":"news","newsList":[{"id":"2435177125","title":"Kymera Therapeutics, Inc.盘中异动 早盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435177125","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435177125?lang=zh_cn&edition=full","pubTime":"2024-05-14 23:11","pubTimestamp":1715699476,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日23时11分，Kymera Therapeutics, Inc.股票出现波动，股价急速跳水5.14%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142311177a59db6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142311177a59db6d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432970247","title":"Kymera Therapeutics, Inc.盘中异动 早盘股价大涨5.04%报38.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432970247","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432970247?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:39","pubTimestamp":1714743564,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时39分，Kymera Therapeutics, Inc.股票出现波动，股价快速上涨5.04%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032139257925c0fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032139257925c0fa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432506436","title":"Kymera Therapeutics, Inc.盘中异动 早盘股价大涨5.03%报35.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432506436","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432506436?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:28","pubTimestamp":1714573709,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日22时28分，Kymera Therapeutics, Inc.股票出现波动，股价大幅上涨5.03%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012228307925a1f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012228307925a1f7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430028997","title":"Kymera Therapeutics, Inc.盘中异动 早盘快速下跌5.20%报33.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430028997","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430028997?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:41","pubTimestamp":1714052481,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时41分，Kymera Therapeutics, Inc.股票出现异动，股价急速下挫5.20%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。该信息摘要如下：Kymera Therapeutics获奥本海默首次覆盖，给予优于大市评级, 目标价53.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252141227923767d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252141227923767d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429157081","title":"Kymera Therapeutics, Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429157081","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429157081?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:29","pubTimestamp":1713882563,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时29分，Kymera Therapeutics, Inc.股票出现异动，股价急速上涨5.14%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。该信息摘要如下：Kymera Therapeutics获奥本海默首次覆盖，给予优于大市评级, 目标价53.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232229237a54f101&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232229237a54f101&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428654967","title":"Kymera Therapeutics, Inc.盘中异动 下午盘快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428654967","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428654967?lang=zh_cn&edition=full","pubTime":"2024-04-19 03:24","pubTimestamp":1713468266,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日03时24分，Kymera Therapeutics, Inc.股票出现异动，股价快速拉升5.04%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419032426861e7221&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419032426861e7221&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426529266","title":"Kymera Therapeutics, Inc.盘中异动 临近收盘急速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426529266","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426529266?lang=zh_cn&edition=full","pubTime":"2024-04-12 03:45","pubTimestamp":1712864731,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日03时45分，Kymera Therapeutics, Inc.股票出现异动，股价快速上涨5.01%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412034532791ff68e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412034532791ff68e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426922394","title":"Kymera Therapeutics, Inc.盘中异动 股价大跌5.70%报35.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426922394","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426922394?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:34","pubTimestamp":1712756052,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时34分，Kymera Therapeutics, Inc.股票出现异动，股价快速跳水5.70%。截至发稿，该股报35.47美元/股，成交量6132股，换手率0.01%，振幅0.92%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102134128b0a717b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102134128b0a717b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424504059","title":"Kymera Therapeutics, Inc.盘中异动 早盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424504059","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424504059?lang=zh_cn&edition=full","pubTime":"2024-04-02 23:15","pubTimestamp":1712070909,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日23时15分，Kymera Therapeutics, Inc.股票出现异动，股价大幅下跌5.29%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.66%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402231509791e808b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402231509791e808b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419904087","title":"Kymera Therapeutics, Inc.盘中异动 股价大涨5.02%报41.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419904087","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419904087?lang=zh_cn&edition=full","pubTime":"2024-03-16 00:27","pubTimestamp":1710520026,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日00时27分，Kymera Therapeutics, Inc.股票出现波动，股价急速上涨5.02%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403160027067a4d1a08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403160027067a4d1a08&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419989849","title":"Kymera Therapeutics, Inc.盘中异动 快速下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419989849","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419989849?lang=zh_cn&edition=full","pubTime":"2024-03-14 23:15","pubTimestamp":1710429352,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日23时15分，Kymera Therapeutics, Inc.股票出现异动，股价急速下跌5.30%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314231552861de466&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314231552861de466&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416640484","title":"Kymera Therapeutics, Inc.盘中异动 大幅拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416640484","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416640484?lang=zh_cn&edition=full","pubTime":"2024-03-01 23:50","pubTimestamp":1709308243,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日23时50分，Kymera Therapeutics, Inc.股票出现异动，股价大幅拉升5.15%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.36%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240301235044861da97f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240301235044861da97f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416466531","title":"美国研究综述-Broadcom、纽约社区银行、TopBuild","url":"https://stock-news.laohu8.com/highlight/detail?id=2416466531","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2416466531?lang=zh_cn&edition=full","pubTime":"2024-03-01 14:50","pubTimestamp":1709275809,"startTime":"0","endTime":"0","summary":"    路透社3月1日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括博通公司、纽约社区银行和 TopBuild。要闻             * 博通公司  ：奥本海默将目标价从1100美元上调至1500美元              * 纽约社区银行  ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。* TopBuild Corp   ：Benchmark将目标价从320美元上调至450美元  以下是路透社周五报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414702837","title":"Kymera Therapeutics Inc2023财年实现净利润-1.47亿美元，同比增加5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414702837","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414702837?lang=zh_cn&edition=full","pubTime":"2024-02-25 00:27","pubTimestamp":1708792041,"startTime":"0","endTime":"0","summary":"12月31日，Kymera Therapeutics Inc公布财报，公告显示公司2023财年净利润为-1.47亿美元，同比增加5.16%；其中营业收入为78.59百万美元，同比增加67.82%，每股基本收益为-2.52美元。从资产负债表来看，Kymera Therapeutics Inc总负债1.81亿美元，其中短期债务6.35百万美元，资产负债比为3.19，流动比率为0.05。机构评级：截至2023年12月31日，当前有14家机构对Kymera Therapeutics Inc目标价做出预测，其中目标均价为47.71美元，其中最低目标价为30.00美元，最高目标价为112.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022500272381b315fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022500272381b315fd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413273894","title":"美国研究综述-Biomarin Pharmaceutical、Intuit、Penumbra","url":"https://stock-news.laohu8.com/highlight/detail?id=2413273894","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413273894?lang=zh_cn&edition=full","pubTime":"2024-02-23 15:28","pubTimestamp":1708673314,"startTime":"0","endTime":"0","summary":"    路透社2月23日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Biomarin Pharmaceutical、Intuit 和 Penumbra。要闻             * Biomarin Pharmaceutical Inc   ：Piper Sandler将目标价从115美元下调至107美元             * Intuit Inc   ：Susquehanna将目标价从700美元上调至775美元             * Penumbra Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413214270","title":"Kymera Therapeutics Inc盘中异动 快速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413214270","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413214270?lang=zh_cn&edition=full","pubTime":"2024-02-22 22:33","pubTimestamp":1708612380,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日22时33分，Kymera Therapeutics Inc股票出现异动，股价快速拉升5.15%。Kymera Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.72%。Kymera Therapeutics Inc公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222223300791381ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222223300791381ee&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413076031","title":"Kymera Therapeutics Inc    预计每股亏损 40 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413076031","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413076031?lang=zh_cn&edition=full","pubTime":"2024-02-21 00:40","pubTimestamp":1708447227,"startTime":"0","endTime":"0","summary":"   * Kymera Therapeutics Inc    将于2月22日公布截至2023年12月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，15位分析师的平均预期显示，这家总部位于马萨诸塞州沃特敦的公司的营收有望从去年同期的1614万美元增长160.0%，达到4196.1万美元。* LSEG分析师对Kymera Therapeutics Inc的平均预期为每股亏损40美分。* 华尔街对Kymera Therapeutics Inc的12个月目标价中位数为33.50美元，低于其最新收盘价38.62美元。2月20日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kymeratx.com","stockEarnings":[{"period":"1week","weight":-0.0871},{"period":"1month","weight":-0.0138},{"period":"3month","weight":-0.0483},{"period":"6month","weight":0.9484},{"period":"1year","weight":0.1736},{"period":"ytd","weight":0.3782}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.0244},{"period":"3month","weight":0.0496},{"period":"6month","weight":0.1623},{"period":"1year","weight":0.267},{"period":"ytd","weight":0.101}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kymera Therapeutics, Inc.，一家根据特拉华州法律于2017年5月25日成立的有限责任公司。该公司是一家生物制药公司，致力于发现和开发新颖的小分子疗法，该疗法可通过利用药物选择性地降解致病蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.111455},{"month":2,"riseRate":0.25,"avgChangeRate":-0.034182},{"month":3,"riseRate":0.25,"avgChangeRate":-0.060002},{"month":4,"riseRate":0.5,"avgChangeRate":-0.04657},{"month":5,"riseRate":0.5,"avgChangeRate":-0.127978},{"month":6,"riseRate":0.666667,"avgChangeRate":0.056418},{"month":7,"riseRate":0.666667,"avgChangeRate":0.103795},{"month":8,"riseRate":0.666667,"avgChangeRate":0.062616},{"month":9,"riseRate":0.25,"avgChangeRate":-0.135819},{"month":10,"riseRate":0.75,"avgChangeRate":0.087377},{"month":11,"riseRate":0.5,"avgChangeRate":0.243236},{"month":12,"riseRate":0.75,"avgChangeRate":0.140141}],"exchange":"NASDAQ","name":"Kymera Therapeutics, Inc.","nameEN":"Kymera Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kymera Therapeutics, Inc.(KYMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kymera Therapeutics, Inc.(KYMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kymera Therapeutics, Inc.,KYMR,Kymera Therapeutics, Inc.股票,Kymera Therapeutics, Inc.股票老虎,Kymera Therapeutics, Inc.股票老虎国际,Kymera Therapeutics, Inc.行情,Kymera Therapeutics, Inc.股票行情,Kymera Therapeutics, Inc.股价,Kymera Therapeutics, Inc.股市,Kymera Therapeutics, Inc.股票价格,Kymera Therapeutics, Inc.股票交易,Kymera Therapeutics, Inc.股票购买,Kymera Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kymera Therapeutics, Inc.(KYMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kymera Therapeutics, Inc.(KYMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}